Form 4: Columbia Financial Inc. Executive Klimowich Reports Stock Transactions
SEC Form 4 Filing
John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc., reports acquisition of common stock and holdings in derivative securities.
Summary
- John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. (CLBK), filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 48.0768 shares of common stock at a price of $13.28 on April 17, 2025, through a stock-based deferral plan.
- Klimowich also holds 59,863 shares of common stock directly and various amounts indirectly through a 401(k) (17,130 shares), ESOP (7,620 shares), SERP (7,051 shares), SIM (4,214 shares), Stock Award II (15,159 shares), Stock Award III (12,068 shares), and Stock Award IV (11,723 shares).
- He also possesses stock options to buy 188,235 shares at $15.60 (fully vested), 12,030 shares at $15.94 (vesting from May 1, 2024), 8,850 shares at $16.49 (vesting from March 6, 2025), and 20,310 shares at $16.23 (vesting from March 3, 2026).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing showing an executive's stock transactions. The acquisition of shares could be seen as mildly positive, but it's not a major event.
Positives
- The acquisition of shares by a key executive could be interpreted as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of stock options and awards suggest a continued commitment to the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the executive's continued investment in the company.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of stock options grant with an exercise price of $15.60. |
| 05/01/2024 | First vesting date for stock options granted at $15.94. |
| 03/06/2025 | First vesting date for stock options granted at $16.49 and stock awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan. |
| 03/03/2026 | First vesting date for stock options granted at $16.23. |
| 03/03/2028 | Vesting date for Stock Award IV if performance-based criteria are met. |
| 04/17/2025 | Date of transaction: acquisition of common stock through stock-based deferral plan. |
| 04/21/2025 | Date of signature for the report. |
Keywords
Form 4, beneficial ownership, stock options, stock awards, Columbia Financial Inc., CLBK, Klimowich, SEVP, Chief Risk Officer, stock-based deferral plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.